Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Safety and Effectiveness of Apixaban, LMWH, and Warfarin Among Venous Thromboembolism Patients with Active Cancer: A Retrospective Analysis Using Four US Claims Databases

Alexander T Cohen, MBBS, MSc, MD, Allison Keshishian, Theodore Lee, MD, Gail Wygant, RN, MS, Lisa Rosenblatt, MD MPH, Patrick Hlavacek, MPH, Jack Mardekian, PhD, Daniel Wiederkehr, MPH, Janvi Sah, MS, Xuemei Luo, PhD

Blood (2019) 134 (Supplement_1): 326.

https://doi.org/10.1182/blood-2019-121769

Published: 2019

Journal Articles

Immune Sculpting of Clonal Hematopoiesis in Advanced and Metastatic Solid Tumors

Eti Sinha, Bhavneet Binder, Olivier Elemento, PhD, Duane C. Hassane, PhD

Blood (2019) 134 (Supplement_1): 3721.

https://doi.org/10.1182/blood-2019-132222

Published: 2019

Journal Articles

Validation of the Khorana Score to Assess Venous Thrombolembolism and Its Association with Mortality

Gulrayz Ahmed, MBBS, Kathryn Tayo Hall, PhD MPH, Lisa Beth Weissmann, MD

Blood (2019) 134 (Supplement_1): 2119.

https://doi.org/10.1182/blood-2019-124240

Published: 2019

Journal Articles

Thrombotic Risk Assessment in a Prospective Cohort of Newly Diagnosed Ambulatory Cancer Patients Candidate to Chemotherapy

Blood (2019) 134 (Supplement_1): 3642.

https://doi.org/10.1182/blood-2019-129901

Published: 2019

Journal Articles

Concurrent Treatment of VEGFR Tyrosine Kinase Inhibitors (TKIs) and Factor Xa Inhibitors Is Associated with Increased Bleeding Risks

Sandip Patel, MBBS, Tiffany George, MD, Tzu-Fei Wang, MD MPH, Sherry Mori Vogt, Pharm D, Edmund Folefac, MD, Ming Yin, MD

Blood (2019) 134 (Supplement_1): 3681.

https://doi.org/10.1182/blood-2019-130465

Published: 2019

Journal Articles

T Cells Expressing an Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor with a Fully-Human Heavy-Chain-Only Antigen Recognition Domain Induce Remissions in Patients with Relapsed Multiple Myeloma

Lekha Mikkilineni, MD, Elisabet E. Manasanch, MD, Norris Lam, BS, Danielle Vanasse, BS, Jennifer N. Brudno, MD, Irina Maric, MD MSci, Jeremy J. Rose, MS, Maryalice Stetler-Stevenson, MD PhD, Hao-Wei Wang, MD PhD, Constance M. Yuan, MD PhD, David F. Stroncek, MD, Jennifer Mann, CRNP, Micaela Ganadan, BSN, RN, Rashmika Patel, Nathan Trinklein, PhD, Ben Buelow, MD PhD, Ronald E. Gress, MD, James N. Kochenderfer, MD

Blood (2019) 134 (Supplement_1): 3230.

https://doi.org/10.1182/blood-2019-129088

Published: 2019

Journal Articles

Red Blood Transfusion Does Not Increase Risk for Venous or Arterial Thrombosis

Lisa Baumann Kreuziger, MD MS, Gustaf Edgren, Ronald G. Hauser, MD, Daniel Zaccaro, Joseph Kiss, MD, Ann Butler Zimrin, MD, Matt Westlake, Donald Brambilla, PhD, National Heart, Lung and Blood Institute Recipient Epidemiology and Donor Evaluation Study-III (REDS-III), Alan E. Mast, MDPhD

Blood (2018) 132 (Supplement 1): 415.

https://doi.org/10.1182/blood-2018-99-109844

Published: 2018

Journal Articles

Developing the Next Generation of iPSC Cell-Based Immunotherapies

Raul Vizcardo, PhD, Nicholas Donald Klemen, MD, Rafiqul Islam, PhD, Devikala Gurusamy, PhD, Naritaka Tamaoki, MD, PhD, Li Jia, PhD, Zhiya Yu, PhD, Amanda N Hennings, PhD, Takuya Maeda, MD, Marta Bosch-Marce, PhD, Meghan L Good, MD, Svetlana Pack, PhD, David F. Stroncek, Francis A Flomerfelt, PhD, Michael J Kruhlak, PhD, Nicholas Phillip Restifo, MD

Blood (2018) 132 (Supplement 1): 3707.

https://doi.org/10.1182/blood-2018-99-118593

Published: 2018

Journal Articles

Pre-Chemotherapy Levels of Hemostatic Biomarkers and Prediction of Prognosis in Newly Diagnosed Metastatic Cancer Patients from the Hypercan Study

Blood (2018) 132 (Supplement 1): 3795.

https://doi.org/10.1182/blood-2018-99-118374

Published: 2018

Journal Articles

Lymphadenopathy in a TB-Endemic Region: Employing Focused Techniques in a Rapid Access Lymph Node Biopsy Clinic

Katherine Rae Antel, Estelle Verburgh, MD PhD, Vernon J. Louw, MD PhD, Jenna Oosthuizen, Francois Malherbe, Maartens Gary, Mark Nicol

Blood (2018) 132 (Supplement 1): 5318.

https://doi.org/10.1182/blood-2018-99-112794

Published: 2018

Journal Articles

Extramedullary Hematopoiesis in the Absence of Myeloproliferative Neoplasm: Mayo Clinic Case Series of 309 Patients

Ni Fan, MD PhD, Sravanthi Lavu, MBBS, Curtis A. Hanson, MD, Ayalew Tefferi, MD

Blood (2018) 132 (Supplement 1): 5457.

https://doi.org/10.1182/blood-2018-99-112587

Published: 2018

Journal Articles

Efficacy of Adjuvant Low Dose Rituximab and Plasma Exchange for Acquired TTP with Severe ADAMTS13 Deficiency — Results of the ART Study

J. Evan Sadler, MD PhD, Joshua Muia, PhD, Leili Dolatshahi, MD, Lisa A. Westfield, MA, Patricia Nieters, RN, BSN, Anita Rodrigues, BA, Ana G. Antun, MD, Ara Metjian, MD, Jeffrey I. Zwicker, MD

Blood (2018) 132 (Supplement 1): 374.

https://doi.org/10.1182/blood-2018-99-113677

Published: 2018

Journal Articles

Periprocedural Interruption of Anticoagulation in Patients with Cancer-Associated VTE: An Analysis of Thrombotic and Bleeding Outcomes

Joseph R. Shaw, MD, James Douketis, MD, Gregoire Le Gal, MD PhD, Marc Carrier, MD MSc

Blood (2018) 132 (Supplement 1): 1235.

https://doi.org/10.1182/blood-2018-99-117715

Published: 2018

Journal Articles

Quantification of Schistocytes from the Peripheral Blood Smear in Thrombotic Thrombocytopenic Purpura (TTP) Compared to Non-TTP Thrombocytopenic Hospitalized Patients

Timothy E. O'Brien, MD, Lynda Bowman, BS, Augustine Hong, Krishna Goparaju, MD BA

Blood (2018) 132 (Supplement 1): 4983.

https://doi.org/10.1182/blood-2018-99-114159

Published: 2018

Journal Articles

Evaluation of Unexplained Lymphadenopathy and Suspected Lymphoma in a Lymphoma Rapid Diagnostic Clinic

Shannon Nixon, NP, Manjula Maganti, MSc, Ksenia Bezverbnaya, BSc, John Kuruvilla, MD, Anca Prica, MD, Robert Kridel, PhD MD, Vishal Kukreti, MD, Patrick Gullane, MD, Michael Reedijk, MD, Melania Pintilie, MSc, Michael Crump, MD

Blood (2018) 132 (Supplement 1): 4739.

https://doi.org/10.1182/blood-2018-99-113515

Published: 2018

Journal Articles

The Use of Thromboelastography in Monitoring Coagulation Status for Patients Treated with Low Molecular Weight Heparin, Warfarin, Apixaban, and Rivaroxaban

Debbie Jiang, MD, Anne Dumont, RN, Adrienne J. Burns, MMS, PA-C, Henry Rinder, MD, Christopher A. Tormey, MD, Alfred Lee, MD PhD

Blood (2017) 130 (Supplement 1): 3741.

https://doi.org/10.1182/blood.V130.Suppl_1.3741.3741

Published: 2017

Journal Articles

Efficacy and Thrombotic Adverse Events of Romiplostim Use in Patients with Thrombocytopenia Related to Underlying Malignancies

Valery J Li, MD, Yimei Miao, BS, Cy Wilkins, MD, Gerald A. Soff, MD

Blood (2017) 130 (Supplement 1): 2324.

https://doi.org/10.1182/blood.V130.Suppl_1.2324.2324

Published: 2017

Journal Articles

Quantification of IGF-1 Receptor May be Useful in the Differential Diagnosis of Essential Thrombocytosis from Reactive Thrombocytosis- Suggested to Add IGF-1Receptor Quantification As the Minor Criteria for the Diagnosis of ET

Guanfang Shi, PhD, Hui Chen, MD, Andrei Bandarchuk, MD, Ching Wong, MD, Vladimir K. Gotlieb, MD, Madhumati Kalavar, MD, Jen-Chin Wang, MD

Blood (2017) 130 (Supplement 1): 5291.

https://doi.org/10.1182/blood.V130.Suppl_1.5291.5291

Published: 2017

Journal Articles

Activated Factors XI and IX and Tissue Factor in Patients with Advanced Cancer

Shannon M Prior, BS, Daniel Douce, MD, Steven Ades, MD MSc, Chris E. Holmes, MD PhD, Samuel Cory, BS, Mary Cushman, MD MSc, Peter Callas, PhD, Saulius Butenas, PhD

Blood (2016) 128 (22): 4947.

https://doi.org/10.1182/blood.V128.22.4947.4947

Published: 2016

Journal Articles

Improved Killing of AML Blasts By Dual-Targeting of CD123 and CD33 Via Unitarg a Novel Antibody-Based Modular T Cell Retargeting System

Claudia Arndt, PhD, Anja Feldmann, PhD, Stefanie Koristka, MSc, Marc Cartellieri, PhD, Malte von Bonin, MD, Armin Ehninger, PhD, Martin Bornhäuser, MD, Gerhard Ehninger, Michael P Bachmann, Prof.

Blood (2015) 126 (23): 2565.

https://doi.org/10.1182/blood.V126.23.2565.2565

Published: 2015

NARROW

Safety and Effectiveness of Apixaban, LMWH, and Warfarin Among Venous Thromboembolism Patients with Active Cancer: A Retrospective Analysis Using Four US Claims Databases

Immune Sculpting of Clonal Hematopoiesis in Advanced and Metastatic Solid Tumors

Validation of the Khorana Score to Assess Venous Thrombolembolism and Its Association with Mortality

Thrombotic Risk Assessment in a Prospective Cohort of Newly Diagnosed Ambulatory Cancer Patients Candidate to Chemotherapy

Concurrent Treatment of VEGFR Tyrosine Kinase Inhibitors (TKIs) and Factor Xa Inhibitors Is Associated with Increased Bleeding Risks

T Cells Expressing an Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor with a Fully-Human Heavy-Chain-Only Antigen Recognition Domain Induce Remissions in Patients with Relapsed Multiple Myeloma

Red Blood Transfusion Does Not Increase Risk for Venous or Arterial Thrombosis

Developing the Next Generation of iPSC Cell-Based Immunotherapies

Pre-Chemotherapy Levels of Hemostatic Biomarkers and Prediction of Prognosis in Newly Diagnosed Metastatic Cancer Patients from the Hypercan Study

Lymphadenopathy in a TB-Endemic Region: Employing Focused Techniques in a Rapid Access Lymph Node Biopsy Clinic

Extramedullary Hematopoiesis in the Absence of Myeloproliferative Neoplasm: Mayo Clinic Case Series of 309 Patients

Efficacy of Adjuvant Low Dose Rituximab and Plasma Exchange for Acquired TTP with Severe ADAMTS13 Deficiency — Results of the ART Study

Periprocedural Interruption of Anticoagulation in Patients with Cancer-Associated VTE: An Analysis of Thrombotic and Bleeding Outcomes

Quantification of Schistocytes from the Peripheral Blood Smear in Thrombotic Thrombocytopenic Purpura (TTP) Compared to Non-TTP Thrombocytopenic Hospitalized Patients

Evaluation of Unexplained Lymphadenopathy and Suspected Lymphoma in a Lymphoma Rapid Diagnostic Clinic

The Use of Thromboelastography in Monitoring Coagulation Status for Patients Treated with Low Molecular Weight Heparin, Warfarin, Apixaban, and Rivaroxaban

Efficacy and Thrombotic Adverse Events of Romiplostim Use in Patients with Thrombocytopenia Related to Underlying Malignancies

Quantification of IGF-1 Receptor May be Useful in the Differential Diagnosis of Essential Thrombocytosis from Reactive Thrombocytosis- Suggested to Add IGF-1Receptor Quantification As the Minor Criteria for the Diagnosis of ET

Activated Factors XI and IX and Tissue Factor in Patients with Advanced Cancer

Improved Killing of AML Blasts By Dual-Targeting of CD123 and CD33 Via Unitarg a Novel Antibody-Based Modular T Cell Retargeting System

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only